These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32149532)

  • 1. Challenges in the development of next-generation antibiotics: opportunities of small molecules mimicking mode of action of host-defense peptides.
    Wang M; Odom T; Cai J
    Expert Opin Ther Pat; 2020 May; 30(5):303-305. PubMed ID: 32149532
    [No Abstract]   [Full Text] [Related]  

  • 2. Do antimicrobial peptides and antimicrobial-peptide resistance play important roles during bacterial infection?
    Cheung GY; Otto M
    Future Microbiol; 2018 Aug; 13(10):1073-1075. PubMed ID: 30113237
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial peptides: their physicochemical properties and therapeutic application.
    Kang SJ; Kim DH; Mishig-Ochir T; Lee BJ
    Arch Pharm Res; 2012 Mar; 35(3):409-13. PubMed ID: 22477186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial resistance to antimicrobial peptides.
    Sahl HG; Shai Y
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3019-20. PubMed ID: 26342677
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial resistance to antimicrobial peptides.
    Abdi M; Mirkalantari S; Amirmozafari N
    J Pept Sci; 2019 Nov; 25(11):e3210. PubMed ID: 31637796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial peptides as an opportunity against bacterial diseases.
    Galdiero S; Falanga A; Berisio R; Grieco P; Morelli G; Galdiero M
    Curr Med Chem; 2015; 22(14):1665-77. PubMed ID: 25760092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surviving innate immunity.
    Nizet V; Gallo RL
    Trends Microbiol; 2002 Aug; 10(8):358-9. PubMed ID: 12160630
    [No Abstract]   [Full Text] [Related]  

  • 8. Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?
    Steinstraesser L; Kraneburg UM; Hirsch T; Kesting M; Steinau HU; Jacobsen F; Al-Benna S
    Int J Mol Sci; 2009 Sep; 10(9):3951-3970. PubMed ID: 19865528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial resistance to cationic antimicrobial peptides.
    Anaya-López JL; López-Meza JE; Ochoa-Zarzosa A
    Crit Rev Microbiol; 2013 May; 39(2):180-95. PubMed ID: 22799636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial γ-AApeptides (WO2013112548): a patent evaluation.
    Teng P; Wu H; Lin L; Cai J
    Expert Opin Ther Pat; 2015 Jan; 25(1):111-8. PubMed ID: 25331592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of host defense peptides in antibiotic-resistant infections.
    Afacan NJ; Yeung AT; Pena OM; Hancock RE
    Curr Pharm Des; 2012; 18(6):807-19. PubMed ID: 22236127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host Defense Peptides: Dual Antimicrobial and Immunomodulatory Action.
    Drayton M; Deisinger JP; Ludwig KC; Raheem N; Müller A; Schneider T; Straus SK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides.
    Melo MN; Dugourd D; Castanho MA
    Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):201-7. PubMed ID: 18221145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and consequences of bacterial resistance to antimicrobial peptides.
    Andersson DI; Hughes D; Kubicek-Sutherland JZ
    Drug Resist Updat; 2016 May; 26():43-57. PubMed ID: 27180309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria.
    Starr CG; Ghimire J; Guha S; Hoffmann JP; Wang Y; Sun L; Landreneau BN; Kolansky ZD; Kilanowski-Doroh IM; Sammarco MC; Morici LA; Wimley WC
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8437-8448. PubMed ID: 32241895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational approaches in efflux pump inhibitors: current status and prospects.
    Rathi E; Kumar A; Kini SG
    Drug Discov Today; 2020 Oct; 25(10):1883-1890. PubMed ID: 32712312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.
    Li J; Fernández-Millán P; Boix E
    Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Polymers: Mimicking Amino Acid Functionali ty, Sequence Control and Three-dimensional Structure of Host-defen se Peptides.
    Hartlieb M; Williams EGL; Kuroki A; Perrier S; Locock KES
    Curr Med Chem; 2017; 24(19):2115-2140. PubMed ID: 28093986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside.
    Maria-Neto S; de Almeida KC; Macedo ML; Franco OL
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3078-88. PubMed ID: 25724815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.